SCHEMBL20214731

SCHEMBL20214731

CCOc1cccc(NC)c1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
GAA P10253 2/20 0.44
LMNA P02545 1/20 0.41
MCL1 Q07820 1/20 0.41
HSD17B10 Q99714 2/20 0.40
KDM4E B2RXH2 2/20 0.40
KMT2A Q03164 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
CYP2C19 P33261 1/20 0.40
MAPK10 P53779 1/20 0.40
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
APP P05067 1/20 0.39
ALOX15 P16050 1/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
MAPT P10636 1/20 0.39
HPGD P15428 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7930788 0.82 ALDH1A1 (0.64) ALDH1A1GAAHSD17B10KDM4EKMT2A
SCHEMBL947416 0.80 GAA (0.58) ALDH1A1GAALMNAMCL1HSD17B10
SCHEMBL7018956 0.80 APP (0.56) GAAKMT2AL3MBTL1APPMEN1
SCHEMBL194451 0.79 ALDH1A1 (0.46) ALDH1A1GAALMNAHSD17B10KDM4E
Hydrochloric Acid SCHEMBL9893410 0.78 APP (0.55) ALDH1A1GAAKMT2AL3MBTL1APP
SCHEMBL1838872 0.76 ALDH1A1 (0.69) ALDH1A1GAAHSD17B10KDM4EKMT2A
SCHEMBL5404445 0.75 ALDH1A1 (0.55) ALDH1A1GAALMNAHSD17B10KDM4E
SCHEMBL20509838 0.75 ALDH1A1 (0.55) ALDH1A1GAAHSD17B10KDM4EKMT2A
SCHEMBL31655455 0.75 ALDH1A1 (0.55) ALDH1A1GAAHSD17B10KDM4EKMT2A
SCHEMBL11354404 0.75 ALDH1A1 (0.55) ALDH1A1GAAHSD17B10KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220089549-A1 INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF UNIV MASSACHUSETTS (US) 2022-03-24 US disclosed
US-11208386-B2 Inhibitors of protein arginine deiminases (PADs) and methods of preparation and use thereof UNIVERSITY OF MASSACHUSETTS (US) 2021-12-28 US disclosed
US-11208386-B2 Inhibitors of protein arginine deiminases (PADs) and methods of preparation and use thereof UNIVERSITY OF MASSACHUSETTS (US) 2021-12-28 US disclosed
US-20200339518-A1 INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF UNIV MASSACHUSETTS (US) 2020-10-29 US disclosed
US-20200339518-A1 INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF UNIV MASSACHUSETTS (US) 2020-10-29 US disclosed
WO-2018102262-A1 INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF UNIVERSITY OF MASSACHUSETTS (US) 2018-06-07 WO disclosed
WO-2018102262-A1 INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF UNIVERSITY OF MASSACHUSETTS (US) 2018-06-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11208386-B2 Inhibitors of protein arginine deiminases (PADs) and methods of preparation and use thereof PADI2, PADI1, PADI4 ALDH1A1 813/4885GAA 2089/4885LMNA 3360/4885
US-20220089549-A1 INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF PADI2, PADI1, PADI4 ALDH1A1 813/4885GAA 2089/4885LMNA 3360/4885
US-20200339518-A1 INHIBITORS OF PROTEIN ARGININE DEIMINASES (PADS) AND METHODS OF PREPARATION AND USE THEREOF PADI2, PADI1, PADI4 ALDH1A1 813/4885GAA 2089/4885LMNA 3360/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.